1. Home
  2. DGII vs NVCR Comparison

DGII vs NVCR Comparison

Compare DGII & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Digi International Inc.

DGII

Digi International Inc.

HOLD

Current Price

$52.21

Market Cap

1.8B

Sector

Technology

ML Signal

HOLD

Logo NovoCure Limited

NVCR

NovoCure Limited

HOLD

Current Price

$10.31

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DGII
NVCR
Founded
1985
2000
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Computer peripheral equipment
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.5B
IPO Year
1995
2015

Fundamental Metrics

Financial Performance
Metric
DGII
NVCR
Price
$52.21
$10.31
Analyst Decision
Strong Buy
Buy
Analyst Count
5
6
Target Price
$48.80
$28.08
AVG Volume (30 Days)
246.9K
1.0M
Earning Date
05-06-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
77.05
21.79
EPS
0.31
N/A
Revenue
$430,221,000.00
$655,353,000.00
Revenue This Year
$18.71
$7.72
Revenue Next Year
$7.22
$6.74
P/E Ratio
$163.13
N/A
Revenue Growth
1.46
8.28
52 Week Low
$22.95
$9.82
52 Week High
$51.78
$20.05

Technical Indicators

Market Signals
Indicator
DGII
NVCR
Relative Strength Index (RSI) 60.99 35.32
Support Level $47.00 N/A
Resistance Level N/A $14.11
Average True Range (ATR) 1.70 0.54
MACD 0.14 -0.14
Stochastic Oscillator 93.93 3.13

Price Performance

Historical Comparison
DGII
NVCR

About DGII Digi International Inc.

Digi International Inc is a Minnesota corporation that provides business and mission-critical Internet of Things (IoT) connectivity products and services. It operates through two segments: IoT Products & Services, which supports OEMs, enterprise, and government customers in deploying secure IoT connectivity solutions, and IoT Solutions, consisting of SmartSense and its Managed Network-as-a-Service (MNaaS) business offering wireless temperature and condition-based monitoring, employee task management, label printing, and other services. The company generates the majority of its revenue from the IoT Products & Services segment and mainly from the United States, with a presence in Europe, the Middle East and Africa, and the Rest of the world.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

Share on Social Networks: